We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.78B
AUM Growth
-$68.3M
(-3.7%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-7.44%
Top 10 Holdings %
Top 10 Hldgs %
16.28%
Holding
390
New
41
Increased
102
Reduced
174
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.23M |
| 2 |
ASRT
Assertio
ASRT
|
+$8.76M |
| 3 |
ITMN
INTERMUNE INC
ITMN
|
+$8.58M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
+$8.51M |
| 5 |
Kforce
KFRC
|
+$8.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$40.2M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$21.7M |
| 3 |
BCOV
Brightcove, Inc.
BCOV
|
+$10.6M |
| 4 |
REXX
Rex Energy Corporation
REXX
|
+$8.91M |
| 5 |
Meritage Homes
MTH
|
+$8.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.87% |
| 2 | Technology | 15.37% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 11.54% |
| 5 | Consumer Discretionary | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Best Buy
BBY
$17.9B
| – | – |
-42,205
| Closed | -$1.68M |
|
352
Boise Cascade
BCC
$2.67B
| – | – |
-24,620
| Closed | -$726K |
|
353
Ciena
CIEN
$53.6B
| – | – |
-198,205
| Closed | -$4.74M |
|
|
CTRA
354
DELISTED
Coterra Energy
CTRA
| – | – |
-22,470
| Closed | -$871K |
|
355
3D Systems Corp
DDD
$430M
| – | – |
-8,312
| Closed | -$772K |
|
356
Danaher
DHR
$142B
| – | – |
-3,995
| Closed | -$207K |
|
357
eBay
EBAY
$50.7B
| – | – |
-9,119
| Closed | -$211K |
|
358
Emerson Electric
EMR
$76.5B
| – | – |
-2,903
| Closed | -$204K |
|
|
GTLS
359
DELISTED
Chart Industries
GTLS
| – | – |
-46,938
| Closed | -$4.49M |
|
360
Illinois Tool Works
ITW
$78.2B
| – | – |
-2,673
| Closed | -$225K |
|
361
Lowe's Companies
LOW
$115B
| – | – |
-4,610
| Closed | -$228K |
|
362
Marathon Petroleum
MPC
$92.1B
| – | – |
-4,686
| Closed | -$215K |
|
|
363
Meritage Homes
MTH
$4.75B
| – | – |
-350,380
| Closed | -$8.41M |
|
364
Nike
NKE
$64.5B
| – | – |
-5,322
| Closed | -$209K |
|
365
RH
RH
$3.48B
| – | – |
-47,536
| Closed | -$3.2M |
|
|
SNBR
366
DELISTED
Sleep Number
SNBR
| – | – |
-190,055
| Closed | -$4.01M |
|
367
Target
TGT
$63.4B
| – | – |
-3,573
| Closed | -$226K |
|
368
TJX Companies
TJX
$172B
| – | – |
-6,356
| Closed | -$203K |
|
369
Taylor Morrison
TMHC
$6.66B
| – | – |
-317,080
| Closed | -$7.12M |
|
370
Vertex Pharmaceuticals
VRTX
$122B
| – | – |
-22,326
| Closed | -$1.66M |
|
371
Traws Pharma
TRAW
$9.3M
| – | – |
-7
| Closed | -$4.22M |
|
|
BCOV
372
DELISTED
Brightcove, Inc.
BCOV
| – | – |
-750,635
| Closed | -$10.6M |
|
|
AKRX
373
DELISTED
Akorn Inc
AKRX
| – | – |
-880,395
| Closed | -$21.7M |
|
|
VIAB
374
DELISTED
Viacom Inc. Class B
VIAB
| – | – |
-2,591
| Closed | -$226K |
|
|
INSY
375
DELISTED
Insys Therapeutics, Inc.
INSY
| – | – |
-354,726
| Closed | -$4.58M |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q1 2014 Portfolio in Review
As of Q1 2014, Emerald Advisers held 390 positions worth $1.78B, down 3.7% from $1.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Emerald Advisers withdrew a net $132M in Q1 2014, closing 34 positions and reducing 174 holdings. Its most notable exit was Akorn Inc, an estimated $21.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Emerald Advisers opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $12.4M.
- Emerald Advisers's largest Q1 2014 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 817,410 shares worth $12.4M.
- Emerald Advisers added most to PacWest Bancorp in Q1 2014, an estimated $7.25M increase.
- Emerald Advisers's biggest Q1 2014 reduction was Intercept Pharmaceuticals, Inc., cutting an estimated $40.2M.
- Emerald Advisers fully exited Akorn Inc in Q1 2014, selling an estimated $21.7M.
- Emerald Advisers's ten largest holdings make up 16% of its $1.78B portfolio in Q1 2014.
- Emerald Advisers opened 41 new positions and closed 34 in Q1 2014.
- Emerald Advisers's portfolio value fell 3.7% quarter-over-quarter to $1.78B.
Based on Emerald Advisers's 13F filing for Q1 2014, filed 30 Apr 2014.